Related Experiment Video
Updated: Aug 17, 2026

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins
Published on: April 26, 2024
Novel target sites in bacteria for overcoming antibiotic resistance
Michael T Black1, John Hodgson
1Novexel SA, Parc Biocitech, 102 route de Noisy, 93230 Romainville, France. mick.black@novexel.com
Abstract:
Resistance to marketed antibiotics continues to increase. During the last 10 years some 200 bacterial genome sequences have become available, giving rise to expectations that genomics would provide a plethora of novel targets and hence a flood of new therapeutic agents. Contrary to some predictions the genomic effort has yet to yield a substantial number of novel class agents in clinical development. What are the reasons for the differences between expectations and reality? This article reviews what has been achieved in the exploitation of bacterial genomes for the discovery of novel antibacterials.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

